Abstract
Aflac will release second-quarter fiscal 2026 results on August 06, 2026, Post Market; this preview covers consensus revenue, margin and EPS expectations, segment dynamics, and the balance of institutional views ahead of the print.
Market Forecast
Based on the latest compiled estimates, Aflac’s current quarter revenue is projected at 4.16 billion US dollars, implying a year-over-year decline of 3.80%; EBIT is forecast at 1.07 billion US dollars with year-over-year growth of 1.76%, and adjusted EPS is estimated at 1.77 with growth of 4.02%. The company’s gross margin and net margin are not formally guided for this quarter, though the prior quarter’s figures remain a reference point for investor modeling. The main business is expected to be anchored by supplemental health insurance net premiums and investment income, while the supplemental health line should remain resilient on stable policy persistency and pricing; the most promising contribution is seen from net investment income as new money yields exceed portfolio roll-offs and alternative investments normalize.
Last Quarter Review
In the previous quarter, Aflac reported revenue of 4.35 billion US dollars, a gross profit margin of 47.31%, GAAP net profit attributable to shareholders of 1.02 billion US dollars, a net profit margin of 23.45%, and adjusted EPS of 1.75, representing year-over-year growth of 5.42%. A key highlight was revenue growth of 27.90% year over year, supported by investment income and stable underwriting, which helped offset headwinds from claim trends. Main business momentum included 3.31 billion US dollars from net premiums in supplemental health insurance and 0.96 billion US dollars from net investment income, underscoring the scale of core underwriting and the growing earnings contribution from the investment portfolio.
Current Quarter Outlook (with major analytical insights)
Supplemental Health Insurance (Core Premiums)
The core supplemental health premiums remain the backbone of Aflac’s quarterly earnings profile, with last quarter’s 3.31 billion US dollars reflecting robust policy persistency and disciplined pricing. For the current quarter, modest top-line pressure versus the prior year is implied by the consolidated revenue forecast, yet underlying premium trends should be steadier than headline revenue given FX translation and the timing of investment-related line items. Claims ratios are expected to remain controlled compared to the pandemic-era volatility, helping preserve underwriting margins. Product refresh cycles in the U.S. and continued distribution productivity in Japan can support stable premium retention; however, yen weakness versus the dollar may dilute reported revenue even if local-currency earned premium holds firm.
Net Investment Income (Most Promising Driver)
Net investment income is positioned to contribute positively as new money yields continue to price above portfolio run-off, gradually lifting the book yield. The estimate for EBIT growth of 1.76% despite a revenue decline suggests margin support from the asset side, as higher recurring coupon income and selective allocation to investment-grade credit bolster operating returns. Alternative and private asset marks have normalized from prior-year volatility, which reduces earnings noise and can incrementally stabilize quarterly results. A measured duration stance and high-quality credit mix reduce tail risk from spread widening, though mark-to-market swings and limited partnership realizations can still introduce quarter-to-quarter variability.
Factors Most Likely to Move the Stock This Quarter
Investor focus is likely to concentrate on the interplay between reported revenue softness and EPS resilience. If underwriting margins mirror last quarter’s gross margin reference point while investment income trends firm, the company could satisfy EPS expectations even with lower sales, supporting valuation stability. Currency effects remain a swing factor; a stronger US dollar versus the yen would pressure reported premiums and fees, potentially masking stable local-currency performance. Management commentary on capital deployment—share repurchases and dividend trajectory—may further influence sentiment if operating earnings cover buybacks without compromising RBC or holding-company liquidity.
Analyst Opinions
Across recent previews and rating updates, the split among published opinions leans mixed-to-cautious, with a modest skew toward neutral or hold stances rather than outright bullish calls. Several institutions emphasize stable underwriting and improving investment yields as supportive for EPS delivery, while pointing to FX headwinds and slower top-line growth as reasons to temper expectations. The majority view anticipates Aflac to meet or slightly exceed EPS consensus while revenue underperforms year over year, favoring a “hold/market-perform” positioning into the print. Cited commentary from well-followed sell-side desks highlights resilient capital return and high-quality credit exposure as positives, counterbalanced by muted premium growth in reported dollars and sensitivity to alternative asset marks.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments